Children with Lennox-Gastaut syndrome (LGS) experience substantial sleep disruptions, which caregivers can track at home with an electroencephalogram (EEG) headband, a study found. The HEADFIRST study showed that the Waveband device, which uses four sensors placed over the front and back of the head to record the brain’s…
News
Two nerve-stimulating devices, vagus nerve stimulation (VNS) and deep brain stimulation (DBS), were associated with similar reductions in seizure frequency over two years in people with Lennox-Gastaut syndrome (LGS), according to a Mayo Clinic study. At two years, however, combined DBS and ongoing VNS was associated with greater seizure…
The initial results from a large, late-stage clinical trial testing an oral seizure treatment for people with Lennox-Gastaut syndrome (LGS) and other epileptic conditions are expected by the end of this year or early next year. That’s according to new updates from Lundbeck, a pharmaceutical company specializing in treating…
Carisbamate, an experimental oral therapy for the treatment of seizures in people with Lennox-Gastaut syndrome (LGS), was generally safe and well-tolerated in children, adolescents, and adults with the disease, according to data from a Phase 1 safety study. The antiseizure medication also showed consistent pharmacokinetics, or how the…
A new mouse model of Lennox-Gastaut syndrome (LGS) accurately reproduced key features of the disease and responded to approved and investigational therapies, providing the first pharmacological validation of the model, a new study reports. “These promising results suggest the mouse model could be a valuable tool for drug discovery…
A girl with difficult-to-treat CDKL5 deficiency disorder (CDD), whose epilepsy later developed into Lennox–Gastaut syndrome (LGS), became seizure-free for more than 11 months after treatment with low-dose Fintepla (fenfluramine), suggesting this medication may be a potential option for similarly hard-to-treat seizures, according to a report from Japan. After starting…
The Lennox-Gastaut Syndrome (LGS) Foundation has launched a collaborative research accelerator to unite experts, dismantle research roadblocks, and speed up the development of new treatments for LGS and related developmental and epileptic encephalopathies (DEEs). The newly formed LGS and Associated DEE Research Accelerator brings together pharmaceutical companies, academic…
A team of experts in Italy has proposed a framework for the routine monitoring of nonseizure symptoms in people with Lennox-Gastaut syndrome (LGS) throughout their lives. While the framework is a good place to start, the researchers noted a need for better assessment tools to adequately capture these symptoms and…
Children with Lennox-Gastaut syndrome (LGS) show significantly higher blood levels of proteins linked to nerve injury and cell death than healthy children, a small study in India suggests. Researchers discovered that these biomarker changes directly track with a heavier seizure burden, raising the possibility that simple blood tests could one…
People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of an international survey conducted by Eurordis-Rare Diseases Europe. Indeed, rare disease patients overall give their healthcare experience a medium-low rating, of 2.5 on a scale of 1 to 5,…
Recent Posts
- EEG headband tracks LGS kids’ sleep disturbances at home
- Making the best of vacationing while caring for a child with LGS
- Combined nerve stimulation linked to greater seizure reductions in LGS
- Navigating my son’s constantly changing eating habits can be tricky
- Effectiveness data due soon from large trial of LGS seizure treatment